Institut Pasteur de Dakar
11
1
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.1%
1 terminated/withdrawn out of 11 trials
83.3%
-3.2% vs industry average
27%
3 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal
Role: lead
African Studies on Aging and Noncommunicable Diseases Epidemiology
Role: collaborator
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Role: collaborator
Performance of the Echopen Probe in Its Clinical Use for Pregnancy Follow-up in Senegal
Role: collaborator
Maternal Probiotic Intervention to Improve Gut Health
Role: collaborator
Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal
Role: lead
Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal
Role: lead
Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old
Role: collaborator
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal
Role: collaborator
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
Role: collaborator
Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal
Role: collaborator
All 11 trials loaded